"These products are called ‘vaccines’ but they based on a completely different model - a completely different platform and delivery system, so they cannot be deemed non-mutagenic until proven otherwise with studies."
If common sense or Precautionary Principle had any place at FDA where evil genius, Monsanto atty as FDA Director created a …
"These products are called ‘vaccines’ but they based on a completely different model - a completely different platform and delivery system, so they cannot be deemed non-mutagenic until proven otherwise with studies."
If common sense or Precautionary Principle had any place at FDA where evil genius, Monsanto atty as FDA Director created a Grand Canyon sized loophole called "substantial equivalence" for gmo foods. It works by measuring a few nutrient levels and compares that to traditional varieties with NO concern for the differences. Close enough for government work.
Fun side note Monsanto and Pfizer merged in 2000 to dump pension & PCB liability as well as "technology exchanges" like field trials of gmo food crops producing animal vaccines...
Here's what FDA rubber stamp looks like...
Compositional Analysis
Based on the nature of the genetic modification, it was not expected that glyphosate-tolerant soybeans would differ compositionally from other soybean varieties. To confirm this expectation, Monsanto carried out compositional analyses which focussed on analysis of whole beans but also included compositional analyses of major soy-derived products, including toasted soybean meal, soy oil, defatted soy flour, and soy protein isolate.
Based on their analysis of whole beans (and, for certain parameters, various soy products), Monsanto has concluded that glyphosate-tolerant soybeans are not significantly different from other soybean varieties in protein, fat, fiber, ash, carbohydrate, amino acid, fatty acid, trypsin inhibitor, lectin, isoflavone (genistein and daidzen), phospholipid (lecithin), phytate, stachyose, or raffinose content. Monsanto's analysis of some of these parameters in glyphosate-treated soybeans led them to similar conclusions.
In order to verify that glyphosate-tolerant varieties of soybeans express levels of soybean allergens no greater than traditional varieties, Monsanto carried out immunoblot analysis using pooled serum from individuals allergic to soybeans. Monsanto reported that there was no difference between glyphosate-tolerant and control lines of soybeans in the level of expression of immunoreactive material.
Wholesomeness Studies
Monsanto described the results of wholesomeness studies they carried out in rats, chickens, catfish, dairy cattle, and bobwhite quail. On the basis of their consideration of the totality of these studies, Monsanto has concluded that there is no significant difference in the wholesomeness of glyphosate-tolerant and traditional soybean varieties, as expected from their compositional analysis. These data are summarized on page 49 of Monsanto's September 2 submission.
Conclusions
Monsanto has concluded, in essence, that the glyphosate-tolerant soybean variety they have developed is not significantly altered within the meaning of 21 CFR 170.30(f)(2) when compared to soybean varieties with a history of safe use. At this time, based on Monsanto's description of its data and analysis, the agency considers Monsanto's consultation on this product to be complete.
yes mam! appreciate your parallel, I have been railing about Glyphosate for over 10 years as my 4 children will attest.. it is in the truest sense now ubiquitous across the this nation and in the vast majority of conventional food( even in the air in New England metropolitan areas)... much of Europe, So America, large portions of Asia.. as of 2 yrs ago the FDAs board had 3 out of 5 members X Monsanto execs...
"These products are called ‘vaccines’ but they based on a completely different model - a completely different platform and delivery system, so they cannot be deemed non-mutagenic until proven otherwise with studies."
If common sense or Precautionary Principle had any place at FDA where evil genius, Monsanto atty as FDA Director created a Grand Canyon sized loophole called "substantial equivalence" for gmo foods. It works by measuring a few nutrient levels and compares that to traditional varieties with NO concern for the differences. Close enough for government work.
Fun side note Monsanto and Pfizer merged in 2000 to dump pension & PCB liability as well as "technology exchanges" like field trials of gmo food crops producing animal vaccines...
Here's what FDA rubber stamp looks like...
Compositional Analysis
Based on the nature of the genetic modification, it was not expected that glyphosate-tolerant soybeans would differ compositionally from other soybean varieties. To confirm this expectation, Monsanto carried out compositional analyses which focussed on analysis of whole beans but also included compositional analyses of major soy-derived products, including toasted soybean meal, soy oil, defatted soy flour, and soy protein isolate.
Based on their analysis of whole beans (and, for certain parameters, various soy products), Monsanto has concluded that glyphosate-tolerant soybeans are not significantly different from other soybean varieties in protein, fat, fiber, ash, carbohydrate, amino acid, fatty acid, trypsin inhibitor, lectin, isoflavone (genistein and daidzen), phospholipid (lecithin), phytate, stachyose, or raffinose content. Monsanto's analysis of some of these parameters in glyphosate-treated soybeans led them to similar conclusions.
In order to verify that glyphosate-tolerant varieties of soybeans express levels of soybean allergens no greater than traditional varieties, Monsanto carried out immunoblot analysis using pooled serum from individuals allergic to soybeans. Monsanto reported that there was no difference between glyphosate-tolerant and control lines of soybeans in the level of expression of immunoreactive material.
Wholesomeness Studies
Monsanto described the results of wholesomeness studies they carried out in rats, chickens, catfish, dairy cattle, and bobwhite quail. On the basis of their consideration of the totality of these studies, Monsanto has concluded that there is no significant difference in the wholesomeness of glyphosate-tolerant and traditional soybean varieties, as expected from their compositional analysis. These data are summarized on page 49 of Monsanto's September 2 submission.
Conclusions
Monsanto has concluded, in essence, that the glyphosate-tolerant soybean variety they have developed is not significantly altered within the meaning of 21 CFR 170.30(f)(2) when compared to soybean varieties with a history of safe use. At this time, based on Monsanto's description of its data and analysis, the agency considers Monsanto's consultation on this product to be complete.
F. Owen Fields, Ph.D.
Page Last Updated: 06/18/2009
https://web.archive.org/web/20101122021318/www.fda.gov/Food/Biotechnology/Submissions/ucm161130.htm
yes mam! appreciate your parallel, I have been railing about Glyphosate for over 10 years as my 4 children will attest.. it is in the truest sense now ubiquitous across the this nation and in the vast majority of conventional food( even in the air in New England metropolitan areas)... much of Europe, So America, large portions of Asia.. as of 2 yrs ago the FDAs board had 3 out of 5 members X Monsanto execs...
"Close enough for government work."
🎯